{"id":"https://openalex.org/W1973180535","doi":"https://doi.org/10.1159/000355268","title":"Gabapentinoid Abuse in Order to Potentiate the Effect of Methadone: A Survey among Substance Misusers","display_name":"Gabapentinoid Abuse in Order to Potentiate the Effect of Methadone: A Survey among Substance Misusers","alternate_titles":[],"publication_year":2013,"publication_date":"2013-10-31","ids":{"openalex":"https://openalex.org/W1973180535","doi":"https://doi.org/10.1159/000355268","mag":"1973180535","pmid":"https://pubmed.ncbi.nlm.nih.gov/24192603"},"language":"en","primary_location":{"id":"doi:10.1159/000355268","doi":"https://doi.org/10.1159/000355268","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000355268","pdf_url":null,"source":{"id":"https://openalex.org/S98083841","display_name":"European Addiction Research","issn_l":"1022-6877","issn":["1022-6877","1421-9891"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Addiction Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1973180535"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045313760","display_name":"Colin R.W. Baird","orcid":"https://orcid.org/0000-0002-1005-1405","observed_orcids":["https://orcid.org/0000-0002-1005-1405"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Colin R.W. Baird","raw_affiliation_strings":["University of Edinburgh, Edinburgh, UK","University of Edinburgh and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Edinburgh, Edinburgh, UK","institution_ids":["https://openalex.org/I98677209"]},{"raw_affiliation_string":"University of Edinburgh and","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Pauline Fox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800150677","display_name":"Western General Hospital","ror":"https://ror.org/009kr6r15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324252669","https://openalex.org/I2800150677"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pauline Fox","raw_affiliation_strings":["Lothian Substance Misuse Service, Western General Hospital, Edinburgh, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lothian Substance Misuse Service, Western General Hospital, Edinburgh, UK","institution_ids":["https://openalex.org/I2800150677"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035280493","display_name":"Lesley Colvin","orcid":"https://orcid.org/0000-0002-1563-8600","observed_orcids":["https://orcid.org/0000-0002-1563-8600"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lesley A. Colvin","raw_affiliation_strings":["University of Edinburgh and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Edinburgh and","institution_ids":["https://openalex.org/I98677209"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.09,"has_fulltext":false,"cited_by_count":170,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9802846,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"20","issue":"3","first_page":"115","last_page":"118"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.996999979019165},{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":1.0},{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.9259999990463257},{"id":"https://openalex.org/keywords/drug-potentiation","display_name":"drug potentiation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/substance-abuse","display_name":"substance abuse","score":0.8420000076293945},{"id":"https://openalex.org/keywords/opioid-use","display_name":"opioid use","score":0.37400001287460327},{"id":"https://openalex.org/keywords/chronic-pain","display_name":"chronic pain","score":0.4320000112056732},{"id":"https://openalex.org/keywords/polysubstance-use","display_name":"polydrug use","score":0.4350000023841858}],"concepts":[{"id":"https://openalex.org/C2776468701","wikidata":"https://www.wikidata.org/wiki/Q412174","display_name":"Pregabalin","level":2,"score":0.7067904472351074},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.6537443399429321},{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.6297290325164795},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5853814482688904},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5081050395965576},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.4682876467704773},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4673269987106323},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3403710722923279},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.12766295671463013},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.07812201976776123},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003625","descriptor_name":"Data Collection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D012606","descriptor_name":"Scotland","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1159/000355268","doi":"https://doi.org/10.1159/000355268","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000355268","pdf_url":null,"source":{"id":"https://openalex.org/S98083841","display_name":"European Addiction Research","issn_l":"1022-6877","issn":["1022-6877","1421-9891"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Addiction Research","raw_type":"journal-article"},{"id":"pmid:24192603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24192603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European addiction research","raw_type":"Journal Article"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire_cris_publications/defae1b5-6015-49d5-b255-4ce005dfdbd1","doi":null,"is_oa":false,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/defae1b5-6015-49d5-b255-4ce005dfdbd1","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Baird, C R W, Fox, P & Colvin, L A 2014, 'Gabapentinoid abuse in order to potentiate the effect of methadone : A survey among substance misusers', European Addiction Research, vol. 20, no. 3, pp. 115-118. https://doi.org/10.1159/000355268","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1943094646","https://openalex.org/W1977980816","https://openalex.org/W1983919275","https://openalex.org/W1997822941","https://openalex.org/W2024007792","https://openalex.org/W2028136394","https://openalex.org/W2038855331","https://openalex.org/W2082351404","https://openalex.org/W2085295826","https://openalex.org/W2090489905","https://openalex.org/W2100385104","https://openalex.org/W2102842111","https://openalex.org/W2103398398","https://openalex.org/W2108417582","https://openalex.org/W2145376332","https://openalex.org/W2149594634","https://openalex.org/W2151792274","https://openalex.org/W2400736836","https://openalex.org/W2412240180","https://openalex.org/W2433672055","https://openalex.org/W7123738272"],"related_works":["https://openalex.org/W2340250473","https://openalex.org/W2583970354","https://openalex.org/W3082895188","https://openalex.org/W3117985481","https://openalex.org/W4383058995","https://openalex.org/W3099018835","https://openalex.org/W2883276235","https://openalex.org/W4389180169","https://openalex.org/W2273108584","https://openalex.org/W3086314190"],"abstract_inverted_index":{"BACKGROUND/AIMS:":[0],"There":[1],"is":[2],"emerging":[3],"evidence":[4,40],"of":[5,20,41,47,54,84],"gabapentin":[6],"and":[7,17,53,94],"pregabalin":[8],"(gabapentinoid)":[9],"abuse,":[10],"particularly":[11],"in":[12,33,60],"the":[13,64],"substance":[14,35,91],"misuse":[15,36,92],"population,":[16],"some":[18],"suggestion":[19],"gabapentinoids":[21,59],"being":[22],"abused":[23,58],"alongside":[24],"methadone.":[25,69],"METHODS:":[26],"A":[27],"questionnaire-based":[28],"survey":[29],"was":[30],"carried":[31],"out":[32],"six":[34],"clinics,":[37],"looking":[38],"for":[39],"gabapentinoid":[42],"abuse.":[43],"RESULTS:":[44],"22%":[45],"(29/129)":[46],"respondents":[48],"admitted":[49],"to":[50,62,86],"abusing":[51],"gabapentinoids,":[52],"these,":[55],"38%":[56],"(11/29)":[57],"order":[61],"potentiate":[63],"'high'":[65],"they":[66],"obtained":[67],"from":[68],"CONCLUSIONS:":[70],"Gabapentinoid":[71],"abuse":[72],"along":[73],"with":[74],"methadone":[75],"has":[76],"not":[77],"previously":[78],"been":[79],"described.":[80],"These":[81],"findings":[82],"are":[83],"relevance":[85],"clinicians":[87],"working":[88],"within":[89],"both":[90],"services":[93],"chronic":[95],"pain":[96],"services.":[97]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1973180535","counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":23},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
